Revolutionizing Solid Tumor Management: Unleashing the Potential of Liquid Biopsy

Join our exclusive webinar, "Revolutionizing Solid Tumor Management: Unleashing the Potential of Liquid Biopsy" for a comprehensive exploration of the groundbreaking world of liquid biopsy in cancer diagnosis and treatment. This session is your opportunity to delve into the key aspects of liquid genomic profiling and its implications for both pathologists and oncologists.

What You'll Learn:
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive into the technical aspects, including Variant Allele Frequency (VAF), Tumor Fraction (TF), and the potential challenges such as false negatives. From the pathology standpoint, we'll walk you through the steps involved in molecular profiling and reporting, shedding light on the laboratory processes and communication of results.

Oncology Perspective: Learn how genomic testing is revolutionizing cancer treatment. Understand how circulating tumor DNA (ctDNA) analysis is applied across various stages of cancer, from late-stage disease management to early- stage detection, screening, risk stratification, and surveillance. From the oncology standpoint, we'll guide you through the steps involved in the practical application of liquid biopsy results in clinical decision-making, including the use of targeted therapies.

Whether you're a healthcare professional, researcher, or simply interested in the future of cancer diagnostics and treatment, this webinar is your gateway to staying informed and up-to-date in this rapidly evolving field. Don't miss this opportunity to expand your knowledge and network with fellow enthusiasts in the world of liquid biopsy. Join us and be a part of the future of cancer care.